FDA's approval of generic version of Doxil could ease shortage

02/5/2013 | MedCityNews.com

The FDA approved the first generic version of the Johnson & Johnson drug Doxil on Monday, which is used to treat multiple myeloma, ovarian cancer and AIDS-related Kaposi's sarcoma. The generic version, which is made by Sun Pharma Global FZE, could help solve a Doxil shortage brought about by quality control problems in the manufacturing process.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care